Vascular endothelial growth factor receptor 2 (VEGFR‐2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells
- 13 July 2011
- journal article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 37 (5) , 538-548
Abstract
Tumours depend on angiogenesis for enhanced tumour cell survival and progression. Vascular endothelial growth factor receptor (VEGFR) signalling plays a major part in this process. Previously, we evaluated tyrosine kinase activity in paediatric brain tumour tissue lysates using a peptide microarray containing 144 different tyrosine kinase peptide substrates. When applied to paediatric pilocytic astrocytoma tissue, this analysis revealed extensive phosphorylation of VEGFR-derived peptides. The aim of the current study was to validate this result and determine the presence of VEGFR-2 activity in paediatric pilocytic astrocytoma as the main VEGFR in terms of mitogenic signalling. In addition, the localization of VEGFR1-3 mRNA expression was assessed. VEGFR-2 phosphorylation was determined by adopting a proximity ligation assay approach. Enrichment of endothelial markers and VEGFRs in tumour endothelium was determined by quantitative polymerase chain reaction (qPCR) analysis of laser-microdissected blood vessels. Proximity ligation assays on tumour cryosections showed the presence of phosphorylation of VEGFR-2, which primarily localized to vascular endothelium. qPCR analysis of endothelial markers and VEGFRs showed a 13.6-fold average enrichment of VEGFR-2 expression in the laser-microdissected endothelium compared to whole tumour. Also the expression of VEGFR-1 and -3 was highly enriched in the endothelium fraction with an average fold-enrichment of 16.5 and 50.8 respectively. Phosphorylated VEGFR-2 is detected on endothelial cells in paediatric pilocytic astrocytoma. Furthermore, endothelial cells are the main source of VEGFR1-3 mRNA expression. This suggests a crucial role for VEGF/VEGFR-induced angiogenesis in the progression and maintenance of these tumours.Keywords
This publication has 56 references indexed in Scilit:
- Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?Neuropathology and Applied Neurobiology, 2010
- Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target DiscoveryCancer Research, 2009
- A small molecule–kinase interaction map for clinical kinase inhibitorsNature Biotechnology, 2005
- From the Archives of the AFIPRadioGraphics, 2004
- Differences in vasculature between pilocytic and anaplastic astrocytomas of childhoodMedical and Pediatric Oncology, 2003
- Pilocytic Astrocytomas in Children: Prognostic Factors—A Retrospective Study of 80 CasesNeurosurgery, 2003
- Long-Term Outcome after Resection of Benign Cerebellar Astrocytomas in Children and Young Adults (0–19 Years): Report of 110 Consecutive CasesPediatric Neurosurgery, 2002
- The Hallmarks of CancerCell, 2000
- Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital.Journal of Clinical Oncology, 1997
- Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literatureChild's Nervous System, 1997